EP3071220
TILBÚIN LYF TIL AÐ MEÐHÖNDLA GD2 JÁKVÆTT KRABBAMEIN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.11.2014EP published:
25.12.2019EP application number:
14802642.0
EP translation filed:
23.1.2020Grant published:
15.2.2020EPO information:
European Patent Register
Max expiry date:
20.11.2034Expiry date:
20.11.2026Next due date:
30.11.2026
Title:
PREPARATIONS FOR TREATING A GD2 POSITIVE CANCER
Timeline
Today
21.11.2014EP application
25.12.2019EP Publication
23.1.2020Translation submitted
15.2.2020Registration published
20.11.2026Expires
Owner
Name:
Apeiron Biologics AGAddress:
Campus-Vienna-Biocenter 5, 1030 Wien, AT
Inventor
Name:
LOIBNER, HansAddress:
A-1230 Vienna, AT
Name:
MUTSCHLECHNER, OliverAddress:
A-2351 Wiener Neudorf, AT
Name:
LADENSTEIN, RuthAddress:
A-1160 Vienna, AT
Name:
KLIER, IsabelAddress:
A-1080 Vienna, AT
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
13193953Date:
21.11.2013Country:
EP
Number:
2834000Date:
21.11.2013Country:
CA
Number:
201314086696Date:
21.11.2013Country:
US
Number:
201414182776Date:
18.2.2014Country:
US
Classification
Categories:
A61K 39/00, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.10.2020
Expires: 20.11.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.10.2021
Expires: 20.11.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.10.2022
Expires: 20.11.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.11.2023
Expires: 20.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 9.11.2023
Expires: 20.11.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.10.2024
Expires: 20.11.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.11.2025
Expires: 20.11.2026
Payer: Árnason Faktor ehf.